Clinical Trials Browser

Phase 4 × Active not recruiting × lorlatinib × Clear all

NCT05144997 2025-12-17

Lorlatinib Continuation Study

Phase 4 Active not recruiting

Carcinoma, Non-Small-Cell Lung